MSSO’s Recommendations for MedDRA Implementation and Versioning for Clinical Trials Transition Date for the Next MedDRA Version * Requires user ID and password to access Membership of the ICH Points to Consider Working Group Current members of the ICH Points to Consider Working Affiliation Member Luisa Casini Commission of the European Communities Kavita Chadda European Federation of Pharmaceutical Hilary Vass* Industries and Associations Christina Winter† Pritchett Health Canada Lynn Macdonald Yutaka Kazuyuki Sekiguchi Japanese Maintenance Organization Mitsuru Takano Tomoko Narita Yo Tanaka Pharmaceutical Manufacturers Hitomi Takeshita Association Miyako Shionoiri MedDRA MSSO Judy Harrison Daisuke Miki Ohta Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Daisuke Sato Devices Agency Yasuko Inokuma Kiyomi Ueno Pharmaceutical Research and Milbhor D’Silva Manufacturers of America
MSSO’s Recommendations for MedDRA Implementation and Versioning for Clinical Trials Transition Date for the Next MedDRA Version * Requires user ID and password to access Membership of the ICH Points to Consider Working Group Current members of the ICH Points to Consider Working Affiliation Member Commission of the European Communities Luisa Casini Kavita Chadda European Federation of Pharmaceutical Industries and Associations Hilary Vass* Christina Winter† Health Canada Pritchett Lynn Macdonald Japanese Maintenance Organization Yutaka Kazuyuki Sekiguchi Mitsuru Takano Tomoko Narita Pharmaceutical Manufacturers Association Yo Tanaka Hitomi Takeshita Miyako Shionoiri MedDRA MSSO Judy Harrison Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency Daisuke Miki Ohta Daisuke Sato Yasuko Inokuma Kiyomi Ueno Pharmaceutical Research and Manufacturers of America Milbhor D’Silva
000012_termselptc_r4_13_mar2017.docx